Lack of association between alpha 1-antichymotrypsin polymorphism, Alzheimer's disease, and allele epsilon 4 of apolipoprotein E

Neurology
U MüllerA Kurz

Abstract

We investigated the possibility that a polymorphism of alpha 1-antichymotrypsin modifies the risk for Alzheimer's disease (AD). Testing 147 AD patients and 74 controls, we did not find evidence of an association between alpha 1-antichymotrypsin polymorphism and AD and also failed to detect a modifying effect of this polymorphism in patients carrying at least one epsilon 4 allele of apolipoprotein E.

Citations

Nov 18, 1998·Annals of Neurology·R Mayeux, R Ottman
Feb 13, 2001·European Journal of Pharmacology·F Richard, P Amouyel
Oct 24, 2002·Neurobiology of Aging·Gianluigi ForloniAlessandro Bertoli
Jan 31, 2006·Neuroimaging Clinics of North America·Bruno P ImbimboNunzio Pomara
Jan 18, 2006·Neuroscience Letters·Giuliana SaltiniIda Biunno
Aug 23, 2011·Immunobiology·Mohammed AiyazSimon Lovestone
Nov 10, 2001·Psychiatric Genetics·W RetzM Rösler
Jun 24, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Claudia PrinzenRolf Postina

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.